Hospices Civils de Lyon
Bron, 69500, France
Location status: Recruiting
Location contact
Anne-Laure CHARLOIS
CONTACT
Sylvain RHEIMS, MD
CONTACT
472359343 ext. +33
Sylvain RHEIMS, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT03094312
Epilepsy affects between 0.5 and 0.7% of the European population. Despite the availability of numerous drug treatments, one third of patients still have seizures, which are associated with significant cognitive and social complications and excess mortality. In these patients, surgical treatment to remove the epileptogenic zone (EZ), the region of the brain responsible for seizures, is the only approach that can allow control of the disease. However, before investigating this surgery, investigations have to answer two questions: (i) what is the location and extension of the EZ and (ii) what functional risks, both motor and cognitive, would represent the resection of this Cortical region? As it is a functional surgery, it is in fact inconceivable that the surgery will result in an over-handicap. For these reasons, all candidates for surgery benefit from a complete assessment including imaging examinations, a neuropsychological assessment and a long-term video-EEG recording to record seizures. Nevertheless, in some patients, this assessment does not give us a formal answer. In these subjects, it is then necessary to carry out a second step, consisting of an invasive exploration by implantation of intracerebral electrodes during a stereoencephalography (SEEG). Due to its temporal and spatial resolution, the SEEG allows, besides the precise determination of the EZ, to carry out a functional mapping of the cortical regions likely to be included in cortectomy. Conventionally, this mapping is carried out on the basis of the cortical electrical stimulations applied to the implanted electrodes. If this approach is very robust for exploring primary functions such as motor skills or language, it cannot be used to evaluate more complex cognitive tasks such as face recognition or attention Effective cognitive treatment on a daily basis. This has led to the development in recent years, in Lyon and Grenoble, of a complementary approach to cerebral stimulation: dynamic spectral imaging (ISD). Numerous experimental paradigms have demonstrated that the realization of a cognitive task associates with the generation within the cortical regions involved in its treatment of a particular cortical activity. This activity is characterized by oscillations of the cortical rhythm in high frequencies (> 30 Hz), called gamma activities. The ISD thus consists in mapping this gamma activity during various cognitive tasks, thus making it possible to study more widely the complexity of the cognitive functions. Correlations between gamma activity and cognitive tasks have so far been exclusively performed in the non-epileptic cortex explored at the periphery of the EA during SEEG. Nevertheless, the cortical oscillatory pattern study associated with a specific cognitive task within the EZ could better anticipate complex cognitive deficits that could be generated by the resection of a cortical region.
The main objective of this project is to establish the predictive character of the gamma cortical oscillatory pattern associated with a specific cognitive task on the risk of occurrence of a cognitive disorder after surgery of epilepsy.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Bron, 69500, France
Location status: Recruiting
Anne-Laure CHARLOIS
CONTACT
Sylvain RHEIMS, MD
CONTACT
472359343 ext. +33
Sylvain RHEIMS, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cerebral stimulation: dynamic spectral imaging (ISD)
Time frame: 12 months post-surgery compare to preoperative assessment (SEEG)
Relation between the presence in the epileptogenic zone of a gamma activation in at least 1 of the cognitive tasks performed during the ISD and the occurrence of a postoperative neuropsychological deficit (Wilcoxon test)
Time frame: pre-surgical assessment (SEEG)
Comparison of mapping of pre-surgical gamma activity with preoperative neu-ropsychological evaluation
Time frame: preoperative assessment (SEEG, fMRI and cortical stimulations)
Pre-surgical comparison of the performances for the functional cartography of gamma activity performed during SEEG, fMRI and cortical stimulation at preoperative assessment.
Time frame: preoperative assessment (SEEG, fMRI and cortical stimulations)
Pre-surgical comparison of the performances for the functional cartography of gamma activity performed during SEEG, fMRI and cortical stimulation at preoperative assessment.
Time frame: 12 months post-surgery compare to preoperative assessment (SEEG)
The relation between the presence in the epileptogenic zone of an activation in the other frequency bands (theta, alpha, beta) in at least 1 of the cognitive tasks performed during the ISD and the occurrence of a post neuropsychological deficit
Time frame: 12 months post-surgery compare to preoperative assessment (SEEG)
The relation between the presence in the epileptogenic zone of an activation in the other frequency bands (theta, alpha, beta) in at least 1 of the cognitive tasks performed during the ISD and the occurrence of a post neuropsychological deficit
Contact information is provided by the study sponsor or research team.
Hospices Civils de Lyon
Other
Acronym: ISD SEEG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05594017
Brain Diseases, Central Nervous System Diseases
Dallas, Texas, United States
View Trial DetailsNCT05065450
Brain Diseases, Brain Injuries
St Louis, Missouri, United States
View Trial DetailsNCT07735715
Brain Diseases, Central Nervous System Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT07228338
Brain Diseases, Central Nervous System Diseases
Dallas, Texas, United States
View Trial Details